Evaluation of immune-mediated idiosyncratic drug toxicity using chimeric HLA transgenic mice
Evaluation of immune-mediated idiosyncratic drug toxicity using chimeric HLA transgenic mice
复制标题
使用嵌合 HLA 转基因小鼠评价免疫介导的特殊药物毒性
DOI:
10.1007/s00204-017-2112-9
复制
发表时间:
2017
影响因子:
6.1
通讯作者:
Ito Kousei
中科院分区:
文献类型:
--
作者:
Susukida Takeshi;Aoki Shigeki;Kogo Kotaro;Fujimori Sota;Song Binbin;Liu Cong;Sekine Shuichi;Ito Kousei
Immune-mediated idiosyncratic drug toxicity (IDT) is a rare adverse drug reaction, potentially resulting in death. Although genome-wide association studies suggest that the occurrence of immune-mediated IDT is strongly associated with specific human leukocyte antigen (HLA) allotypes, these associations have not yet been prospectively demonstrated. In this study, we focused on HLA-B*57:01 and abacavir (ABC)-induced immune-mediated IDT, and constructed transgenic mice carrying chimeric HLA-B*57:01 (B*57:01-Tg) to determine if this in vivo model may be useful for evaluating immune-mediated IDT. Local lymph node assay (LLNA) results demonstrated that percentages of BrdU+, IL-2+, and IFN-γ+in CD8+T cells of ABC (50 mg/kg/day)-applied B*57:01-Tg mice were significantly higher than those in littermates (LMs), resulting in the infiltration of inflammatory cells into the ear. These immune responses were not observed in B*57:03-Tg mice (negative control). Furthermore, oral administration of 1% (v/v) ABC significantly increased the percentage of CD44highCD62LlowCD8+memory T cells in lymph nodes and spleen derived from B*57:01-Tg mice, but not in those from B*57:03-Tg mice and LMs. These results suggest that B*57:01-Tg mice potentially enable the reproduction and evaluation of HLA-B*57:01 and ABC-induced immune-mediated IDT.